Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Drug Screening Market Will Reach USD 6333.1 Million By 2028 With A CAGR of 5.6%- Valuates Reports


BANGALORE, India, May 16, 2022 /PRNewswire/ -- Drug Screening Market is segmented by Type - Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents, Segment by Application - Hospitals, Research Institute, Biotechnology & Pharmaceutical Companies, Others. It is published in Valuates Reports under the  Pharmaceuticals & Biotech Category.

Valuates_Reports_Logo

The Drug Screening market size is estimated to be worth USD 4567.1 million in 2022 and is forecast to be a readjusted size of USD 6333.1 million by 2028 with a CAGR of 5.6% during the review period.

Major Factors Driving The Growth Of The Drug Screening Market

The increased consumption of drugs and alcohol, and the implementation of strict laws requiring drug and alcohol testing are all contributing to the growth of the global drug screening market in the near future. 

Browse The Table of Contents And List of Figures At https://reports.valuates.com/market-reports/QYRE-Auto-2I7206/global-drug-screening

TRENDS INFLUENCING THE GROWTH OF THE DRUG SCREENING MARKET

Growing drug and alcohol consumption is expected to create lucrative growth opportunities for the drug screening market growth. According to the World Drug Report 2021, an estimated 275 million people worldwide aged 15?64, or 1 in every 18 people in that age group, have used drugs at least once in the previous year (range: 175 million to 374 million). As an employer, you have a responsibility to provide a safe working environment for your employees. Pre-employment drug screenings and random testing are two of the most effective ways to keep your workplace drug-free.

Furthermore, the COVID-19 pandemic led to an increase in drug abuse. This in turn is expected to fuel the drug screening market. More than 100 million people were displaced by the COVID-19 crisis. Mental health problems are also on the rise around the world. As a result, drug abuse may become more prevalent. Parallel to this, drug traffickers have quickly recovered from initial setbacks caused by lockdown restrictions, thanks in part to an increase in the use of technology (drug traffickers using online platforms, for example) and cryptocurrency payments that operate outside of the traditional financial system. These factors will almost certainly boost demand for drug screening products and services.

The drug screening market is expected to grow due to the rising demand for immunoassay analyzers in hospitals and clinical laboratories. Antibodies or antigens are used in immunoassay tests to detect the presence of drugs. They're cheap, quick to process, and most commonly used for initial screening, providing a simple yes or no answer. Immunoassay analyzers use an antibody as a reagent to identify and detect the concentration of specific substances in a sample. These devices are capable of performing a wide range of tests, including cancer screening, allergy testing, therapeutic drug monitoring, and more.

The drug screening market is expected to grow as law enforcement uses breathalyzers more frequently. The device is used by cops to determine how much alcohol is in the system of people suspected of being drunk.

However, the restrictions on alcohol consumption in various Islamic nations and the ban on drug testing at office premises in other locations, on the other hand, are two important concerns that could stymie the expansion of the global drug screening market in the near future.

 Get Your Sample Today: https://reports.valuates.com/request/sample/QYRE-Auto-2I7206/Global_Drug_Screening_Market

DRUG SCREENING MARKET SHARE ANALYSIS

Based on region, North America is expected to be the most lucrative segment. Factors such as the rising consumption of illicit drugs, the availability of government funding to combat drug abuse, laws supporting drug screening, the rising burden of accidents caused by alcohol impairment, and the presence of key players in the region are all driving the growth of the drug screening market in this region.

Based on application, the Hospitals segment is expected to be the most lucrative segment. This is due to an increase in drug screening in hospitals in order to maintain a healthy working environment, as well as the number of admitted patients with severe drug abuse issues. Drug testing is also required for clinical care, occupational health, and legal prosecution.

Inquire For Customization: https://reports.valuates.com/request/customisation/QYRE-Auto-2I7206/Global_Drug_Screening_Market

Market By Region

Inquire For Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-2I7206/Global_Drug_Screening_Market

Key players

Inquire For Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-2I7206/Global_Drug_Screening_Market

Buy Now for Single User + Covid-19 Impact : https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-2I7206&lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS

-  The global Orphan Drugs market size is projected to reach USD 241610 million by 2027, from USD 122720 million in 2020, at a CAGR of 9.7% during 2021-2027.

-  The global Alcohol Breathalyzer and Drug Testing market size is projected to reach USD 6389.6 million by 2027, from USD 3754 million in 2020, at a CAGR of 7.9% during 2021-2027.

-  The global At-Home Drug of Abuse (DOA) Testing market size is projected to reach USD 862.3 million by 2028, from USD 413.2 million in 2021, at a CAGR of 10.6% during 2022-2028.

-  The global Drug of Abuse Testing Services market size is projected to reach USD 2714.1 million by 2027, from USD 1556.2 million in 2020, at a CAGR of 7.8% during 2021-2027.

-  The global Drug Testing market size is projected to reach USD 3430.9 million by 2028, from USD 2788.7 million in 2021, at a CAGR of 2.6% during 2022-2028.

Global Bacterial Identification and Drug Sensitivity Testing Market Insights and Forecast to 2028

Global Analytical Instruments for Drug Screening Market Insights, Forecast to 2028

Global Drug Screening Equipment Market Insights and Forecast to 2028

Global Drug Screening Test Kit Market Research Report 2022

Global Drug Screening Laboratory Service Market Insights and Forecast to 2028

Global Drug Designing Tools Market Insights and Forecast to 2028

Global Workplace Drug Testing Service Market Insights and Forecast to 2028

Click Here To See Related Reports on Drug Screening Market

About Us:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

Contact Us:

Valuates Reports 
[email protected] 
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com   
Twitter - https://twitter.com/valuatesreports

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg


These press releases may also interest you

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

24 avr 2024
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

24 avr 2024
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

24 avr 2024
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...

24 avr 2024
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...



News published on and distributed by: